2021 could be a big year for this soon-to-be $16-trillion biotech industry.
More importantly, it could be a big year for early investors in this new biotech breakthrough that could effectively treat the world’s #1 disability.
It’s a disability that’s costing the economy $1 trillion in lost production every single year.
In fact, the revolutionary treatment could be at our doorstep by 2021.
In clinical trials it’s successfully treated 80% of patients (see below).
Investors are piling in.
They call this new segment of biotech ‘transformational medicine'…
The next few months are critical.
Why? Global spending on mental healthcare could hit $16 trillion by 2030.
The science may read like the best of Isaac Asimov, but it's very real.
Researchers say it could have huge implications for people with...
- Depression and anxiety
- PTSD
- Addiction
- Bipolar Disorder, OCD and Schizophrenia
- Autism
- Alzheimer’s and Parkinson’s
- And many other disabling diseases…
And it's all thanks to four naturally occurring “miracle compounds” that help "reset" the human brain...
With the potential to transform the mental health of hundreds of millions starting as early as 2021.